|
|
|
|
pmid:28302565
|
|
|
|
|
pmid:28189120
|
|
|
|
|
pmid:25190453
|
|
|
|
|
pmid:25184787
|
|
|
|
|
pmid:25181418
|
|
|
|
|
pmid:27256330
|
|
|
|
|
pmid:27255234
|
|
|
|
|
pmid:26447026
|
|
|
|
|
pmid:24975835
|
|
|
|
|
pmid:24948035
|
|
|
|
|
pmid:26923849
|
|
|
|
|
pmid:26909563
|
|
|
|
|
pmid:24697526
|
|
|
|
|
pmid:24689950
|
|
|
|
|
pmid:26584851
|
|
|
|
|
pmid:26581047
|
|
|
|
|
pmid:24249810
|
|
|
|
|
pmid:24212399
|
|
|
|
|
pmid:26362186
|
|
|
|
|
pmid:26361088
|
|
|
|
|
pmid:26112994
|
|
|
|
|
pmid:26099662
|
|
|
|
|
pmid:25866993
|
|
|
|
|
pmid:25865548
|
|
|
|
|
pmid:28260080
|
|
|
|
|
pmid:28259984
|
|
|
|
|
pmid:25643339
|
|
|
|
|
pmid:25634035
|
|
|
|
|
pmid:27849387
|
|
|
|
|
pmid:27845067
|
|
|
|
|
pmid:25446166
|
|
|
|
|
pmid:25442456
|
|
|
|
|
pmid:27664484
|
|
|
|
|
pmid:27663616
|
Wang Y et al. |
Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. |
|
Phytomedicine |
pmid:24854571
|
|
|
|
|
pmid:12354528
|
|
|
|
|
pmid:
|
Yamamoto N et al. |
Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. |
|
Prostaglandins Other Lipid Mediat. |
pmid:25677506
|
Hofbauer LC and Heufelder AE |
Osteoprotegerin: a novel local player in bone metabolism. |
1997 |
Eur. J. Endocrinol. |
pmid:9368500
|
Simonet WS et al. |
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. |
1997 |
Cell |
pmid:9108485
|
Horwood NJ et al. |
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. |
1998 |
Endocrinology |
pmid:9794488
|
Vidal NO et al. |
Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. |
1998 |
J. Endocrinol. |
pmid:9795357
|
Filvaroff E and Derynck R |
Bone remodelling: a signalling system for osteoclast regulation. |
1998 |
Curr. Biol. |
pmid:9768352
|
Akatsu T et al. |
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. |
1998 |
Bone |
pmid:9855457
|
Morinaga T et al. |
Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. |
1998 |
Eur. J. Biochem. |
pmid:9688283
|
Emery JG et al. |
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. |
1998 |
J. Biol. Chem. |
pmid:9603945
|
Tsukii K et al. |
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9610359
|
Mizuno A et al. |
Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. |
1998 |
Gene |
pmid:9714833
|
Yun TJ et al. |
OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. |
1998 |
J. Immunol. |
pmid:9834095
|
Murakami T et al. |
Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9837778
|